Dr. Stekler began her career working to expand routine HIV antibody testing and access to pooled HIV nucleic acid amplification testing to diagnose acute HIV infection. She has led several studies investigating novel methods to diagnose acute and early HIV infection; comparisons of point-of-care HIV tests; and home, self-testing for HIV infection. Her current work is evaluating the feasibility of implementing point-of-care nucleic acid tests for HIV diagnosis and treatment monitoring in community and clinical sites in Seattle.
Her other interests include HIV pre-exposure prophylaxis (PrEP) and use of technology for HIV prevention Dr. Stekler started the first community-based PrEP clinic in Seattle in 2013 and the first telePrEP clinic in 2015. Through collaborations with the Washington State Department of Health and Mountain West AIDS Education and Training Center, she has been working to expand access to PrEP to reduce healthcare disparities among populations disproportionately impacted by HIV.
- HIV prevention, particularly increasing PrEP access among populations disproportionately impacted by HIV, PrEP adherence, and provider education.
- HIV testing strategies
- Digital health
- HIV prevention and care
- Pre-exposure prophylaxis
education & training
MD, Duke University School of Medicine, Durham NC (1997)
MPH, University of Washington, Seattle WA (2004)
Residency, University of Washington, Seattle WA (1997-2000)
Senior Fellowship, University of Washington, Seattle WA (2002-2005)
Phi Beta Kappa
2012 Philip and Helen Fialkow Scholar
Award to a junior faculty member in medicine to recognize outstanding achievements in research, teaching, clinical work and academic citizenship.
2013 HIV/AIDS Service Award and Keynote, 10th Annual World AIDS Day Breakfast
Awarded to honor “tireless efforts and visionary leadership in the fight against HIV/AIDS.”
UW School of Medicine Preceptor Award for Service Learning
Award to a preceptor for a significant commitment to community service, service-learning, and advocacy. Awards received in 2017 and 2018.